Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/12.5 mg, 90 tablets bottles, Rx Only...

FDA Recall #D-0756-2022 — Class II — March 21, 2022

Recall #D-0756-2022 Date: March 21, 2022 Classification: Class II Status: Terminated

Product Description

Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/12.5 mg, 90 tablets bottles, Rx Only Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0220-23.

Reason for Recall

CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.

Recalling Firm

Pfizer Inc. — New York, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1364 bottles

Distribution

Nationwide

Code Information

Lot EA6665, Exp Date 04/2022, Lot CN0640, Exp Date 04/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated